MANAGEMENT TEAM

EMIL MALAK

Founder, CEO & Director

Emil Malak is the largest single shareholder of Voip-Pal stock. He was a co-founder of Digifonica in 2003 and oversaw the development of the patents which were acquired by Voip-Pal in 2013. Mr. Malak also serves as Chairman of the Board for a biotech company currently conducting cancer research in Germany.

D. BARRY LEE

Chief Financial Officer & Director

D. Barry Lee is an experienced senior management consultant with proven abilities in all aspects of business, providing financial management, consulting and advisory services to private and public companies. He has over 30 years of experience working with public and private companies with particular expertise in financial management across various sectors including domestic and international energy, technology, real estate and resources. He has an extensive history in a broad spectrum of corporate endeavors, including start‐ups, mergers and acquisitions and restructurings,corporate governance and public company compliance.

DR. RYAN THOMAS

Advisor

Dr. Ryan Thomas has served as Voip-Pal's in-house counsel since 2013. He has been practicing law since 1979 and has over 35 years experience as a litigator. Over the course of his career he has served on many business and professional boards and held several key administrative positions. He is also a teacher of law and business. Dr. Thomas has a strong technological and computer science background and has extensive experience in patent law. During his tenure with Voip-Pal he has been instrumental in advising the Company on a variety of important legal matters.

DR. ROLAND FRANKE

Advisor

Dr. Franke has an extensive background both as a scientific research leader and as a successful business executive.  He has conducted extensive research, focusing largely on oncology, while simultaneously serving in the capacity of CEO or other key management role that has garnered him significant transaction experience.  Since 2017, Dr. Franke has served as the Chief Scientific Officer & VP of Business Development of OncoGenerix, a company engaged in research and production of oncology pharmaceuticals.  Since 2016, he has served as adviser to the Chairman of Phyton Biotech, a nanotechnology company focused on oncology, where he previously served as CTO & VP of Business Development starting in 2009.  Dr. Franke founded Natural Pharmaceuticals, a biopharmaceutical company, in 1998, where he served as CEO until the end of 2009. He was previously a consultant at Booz Allen & Hamilton, where he consulted on significant M&A transactions focused on pharmaceuticals and biotechnology.  Dr. Franke holds an MS/MBA from the Sloan School of Management (MIT), a PhD in Chemistry from MIT, and a masters in Chemistry from the University of Freiberg,

DR. PENTTI HUTTUNEN, PHD

Engineer/Consultant

Dr. Huttunen has been a part of Digifonica since 2006.  He is an engineer and a co-inventor on several Digifonica patents. He attained a Masters Degree and a PhD in Computer Science from Lappeenranta University of Technology in Finland. His background includes working as a Senior Software Engineer for Intel and Senior Web Architect for Nokia. During his time at Digifonica, Dr Huttenen was the R&D Manager and was instrumental in overseeing the operation of Digifonica’s three supernodes in Canada, the United Kingdom and Denmark. Currently he is working as Director of Research & Development at Mobiliya and continues to serve as a technology consultant for Voip-Pal.

DR. ALEX KRAPYVNY, PHD

Engineer/Consultant

Dr. Krapyvny is one of the founders of Digifonica and has worked with Digifonica/Voip-Pal as an engineer since 2003. He is a graduate of Zaporozhye State University in the Ukraine and Moscow Sate University in Russia. He has a Master’s Degree in Theoretical Physics and a PhD in Mathematics. Dr Krapyvny has served as a technical consultant on software applications for Digifonica and Voip-Pal.

All statements contained in this website, other than those identifying historical facts, constitute "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934 and the Safe Harbor provisions as contained in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relating to the Company's future expectations, including but not limited to revenues and earnings, technology efficacy, strategies and plans, are subject to safe harbors protection. Actual Company results and performance may be materially different from any future results, performance, strategies, plans, or achievements that may be expressed or implied by any such forward-looking statements. The Company disclaims any obligation to update or revise any forward-looking statements.

© 2019 VOIP-PAL.COM. All Rights Reserved.

  • Facebook Social Icon
  • Twitter Social Icon